We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LLY Eli Lilly and Co

11.03 (1.87%)
Dec 08 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 2,446,867
Bid Price
Ask Price
News (2)
Day High 598.30


52 Week Range


Day Low 584.77
Share Name Share Symbol Market Stock Type
Eli Lilly and Co LLY NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
11.03 1.87% 599.30 19:00:00
Open Price Low Price High Price Close Price Previous Close
589.43 584.77 598.30 598.05 588.27
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
71,672 2,446,867 US$ 591.54 US$ 1,447,424,452 - 302.14 - 629.97
Last Trade Type Quantity Price Currency
18:59:46 15 US$ 598.60 USD

Eli Lilly (LLY) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Eli Lilly and Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
567.73B 949.31M - 28.54B 6.24B 6.58 90.91
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Eli Lilly News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No LLY Message Board. Create One! See More Posts on LLY Message Board See More Message Board Posts

Historical LLY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week591.70601.97574.33586.662,510,2647.601.28%
1 Month595.53618.75574.33594.642,935,1103.770.63%
3 Months592.43629.97516.57582.363,218,8906.871.16%
6 Months436.01629.97432.34540.893,008,643163.2937.45%
1 Year373.26629.97302.14452.353,043,184226.0460.56%
3 Years147.28629.97146.91317.863,119,443452.02306.91%
5 Years113.60629.97101.36216.094,062,112485.70427.55%

Eli Lilly Description

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |